Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

COCO May 9, 2026

Vita Coco Q1 2026 Earnings Call - Coconut Water Category Accelerates as Brand Gains Mainstream Traction

Vita Coco delivered a blistering first quarter, with net sales jumping 37% year-over-year to $180 million and adjusted EBITDA climbing to $39 million. The growth was fueled by a 42% surge in branded c...

  • Net sales surged 37% year-over-year to $180 million, driven by a 42% increase in branded coconut water and 28% growth in private label shipments.
  • Adjusted EBITDA jumped to $39 million, representing a 22% margin, up from 17% in Q1 2025, reflecting strong pricing and lower ocean freight costs.
  • Management raised full-year net sales guidance to $720–$735 million and adjusted EBITDA to $132–$138 million, citing accelerating demand and improved capacity utilization.
  • +7 more takeaways
SBGI May 9, 2026

Sinclair Broadcast Group Q1 2026 Earnings Call - Broadcast Reaffirms Guidance Amid Sports Surge and Deleveraging Progress

Sinclair Broadcast Group delivered a solid first quarter with revenue up 4% to $807 million and Adjusted EBITDA growing 13% to $126 million. The results highlight the resilience of the core broadcast ...

  • Total revenue reached $807 million, a 4% year-over-year increase, with Adjusted EBITDA up 13% to $126 million, reflecting strong operating leverage and disciplined cost management.
  • Core advertising revenue grew 4% year-over-year, supported by live sports momentum and the Digital Remedy acquisition, though management noted reduced advertiser visibility due to macro headwinds.
  • Distribution revenue increased 2% to $458 million, driven by lower subscriber churn across key MVPDs and incremental benefits from recently closed partner station buy-ins.
  • +7 more takeaways
RIVN May 9, 2026

Rivian Q1 2026 Earnings Call - R2 Production Begins, Autonomy Roadmap Accelerates, and Georgia Plant Capacity Increased

Rivian has officially kicked off saleable R2 production at its Normal, Illinois plant, marking a pivotal shift toward mass-market EVs and a structural path to profitability. The R2’s bill of materials...

  • Rivian has started saleable R2 production at its Normal, Illinois plant, with initial deliveries to employees and customers beginning in spring 2026.
  • The R2’s bill of materials is approximately half that of the R1, with non-BOM COGS reduced by more than 50% through design-for-manufacturing and fixed-cost leverage.
  • Automotive gross profit is expected to turn positive by the end of 2026, though Q2 and Q3 will face temporary margin pressure from R2 ramp complexity and lower volumes.
  • +7 more takeaways
GAIA May 9, 2026

Gaia Q1 2026 Earnings Call - Gaia Pivots to Direct Memberships with 15% Price Hike

Gaia’s Q1 2026 earnings call highlighted a strategic pivot away from third-party platform growth toward a higher-quality, direct membership model. The company implemented a 15% price increase in 80% o...

  • Gaia implemented a 15% price increase in approximately 80% of its regions for monthly members in March 2026, with annual members subject to the increase upon renewal.
  • The company is strategically pivoting away from third-party platform growth to prioritize direct memberships, aiming for a 20% reduction in churn and a 20-25% increase in ARPU by Q4 2026.
  • Q1 2026 revenue reached $24.3 million, up from $23.8 million in Q1 2025, driven by increased ARPU and partially offset by reduced discounting.
  • +9 more takeaways
TAP May 9, 2026

Molson Coors Beverage Company Q1 Fiscal Year 2026 Earnings Call - Reaffirms Full-Year Guidance Amid Portfolio Shifts and Cost Pressures

Molson Coors delivered a mixed Q1 FY2026, with underlying EPS up 24% and pre-tax income up 16.2%, but U.S. beer volume share slipped 60 basis points as macro headwinds and regional competitive pressur...

  • Underlying EPS surged 24% and pre-tax income rose 16.2% in Q1 FY2026, driven by pricing and cost discipline, despite a 0.1% constant-currency sales decline.
  • U.S. beer volume share fell 60 basis points, with Miller Lite facing regional competitive pressures and Keystone Light requiring attention in the value segment.
  • Molson Coors acquired Monaco Cocktails, adding immediate scale in the RTD space and retaining 80 sales personnel to bolster beyond-beer execution.
  • +7 more takeaways
PCRX May 9, 2026

Pacira BioSciences Q1 2026 Earnings Call - EXPAREL Growth Accelerates Amid Strong Commercial Execution and Pipeline Catalysts

Pacira BioSciences delivered a robust first quarter in 2026, with total net sales rising as momentum from late 2025 carried forward. The flagship product EXPAREL led the charge, posting 7% volume grow...

  • EXPAREL net sales reached $143.3 million in Q1 2026, up from $136.5 million in Q1 2025, driven by 7% volume growth despite vial mix shifts and a new GPO agreement.
  • Commercial payer coverage for EXPAREL outside the surgical bundle has surpassed 110 million covered lives, supported by the NOPAIN Act and expanding market adoption.
  • ZILRETTA sales increased 15% year-over-year to $26.8 million, fueled by a dedicated sales force and a strategic collaboration with Johnson & Johnson MedTech.
  • +9 more takeaways
FLS May 9, 2026

Flowserve Q1 2026 Earnings Call - Reaffirms $4.00-$4.20 EPS Amid Middle East Disruption and Strong Margin Expansion

Flowserve delivered a resilient first quarter in 2026, posting adjusted EPS of $0.85, up 18% year-over-year, and expanding adjusted operating margins by 230 basis points to 15.1%. The results reflect ...

  • Adjusted EPS of $0.85 exceeded expectations, up 18% year-over-year, driven by 230 basis points of operating margin expansion and a $0.19 benefit from IEPA tariff refunds.
  • Full-year adjusted EPS guidance remains unchanged at $4.00-$4.20, implying mid-single-digit growth over 2025, despite Q1 headwinds.
  • Revenue fell 7% to $1.1 billion, hampered by a 2% negative impact from Middle East disruptions and a softer start to North American MRO bookings in January and February.
  • +7 more takeaways
LPLA May 9, 2026

LPL Financial Q1 2026 Earnings Call - Record EPS and Commonwealth Integration Progress Drive Operating Leverage

LPL Financial delivered a strong start to 2026 with record adjusted EPS of $5.60, up 9% year-over-year, driven by organic growth and disciplined expense management. Total assets declined to $2.3 trill...

  • LPL Financial reported record adjusted EPS of $5.60, a 9% increase year-over-year, reflecting strong financial performance despite macro headwinds.
  • Total client assets declined to $2.3 trillion as market depreciation offset $21 billion in organic net new assets, achieving a 4% annualized growth rate.
  • The firm advanced its integration with Commonwealth Financial Network, targeting 90% asset retention by year-end, with current retention in the mid-80s.
  • +7 more takeaways
AMGN May 9, 2026

Amgen

Amgen delivered a strong first quarter of 2026, driving 4% product sales growth that outpaced the drag from patent expirations on legacy brands like Prolia and Xgeva. The company’s six key growth driv...

  • Amgen’s six key growth drivers, including Repatha, Tezspire, and Uplizna, generated 70% of product sales in Q1 2026 and grew 24% year-over-year.
  • Product sales rose 4% year-over-year, outpacing the financial impact of patent expirations on legacy brands like Prolia and Xgeva.
  • MariTide, a long-acting antibody-peptide conjugate for obesity and type 2 diabetes, initiated two new phase III studies evaluating monthly, every-eight-week, and every-12-week dosing schedules.
  • +7 more takeaways
TTI May 9, 2026

TETRA Technologies Q1 2026 Earnings Call - Record Q1 Revenue Driven by Deepwater Growth and Strategic Critical Minerals Expansion

TETRA Technologies delivered a standout first quarter of 2026, recording 10-year highs in revenue and adjusted EBITDA despite a turbulent macro backdrop. The company’s strategic pivot toward deepwater...

  • Q1 2026 revenue reached $156 million, a 10-year high, while adjusted EBITDA hit $26 million, also a 10-year high, excluding the prior year’s Neptune project tailwind.
  • The industrial chemicals sub-segment posted record revenue, up 15% year-over-year and 13% quarter-over-quarter, now representing over 50% of total segment revenue.
  • Deepwater completion fluids in Brazil and the Gulf of Mexico achieved 10-year highs, with growing demand for higher-density zinc bromide fluids in hotter, deeper wells.
  • +9 more takeaways